Resolution adopted by the extraordinary general meeting of Vitrolife

For purposes of Vitrolife’s offer to the shareholders of MediCult, the general meeting on 19 February 2009 resolved, in accordance with the board’s proposal, to authorise the board to issue new shares, to be paid for in kind, on one or several occasions up to the next annual general meeting.




Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 61